Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02030665 · ClinicalTrials.gov registry record · NA

Marijuana Treatment Project 4

A NA study of Marijuana Dependence, sponsored by UConn Health.

Completed
Registry status
NA
Development phase
198
Enrollment target
1
Study location

NCT02030665 is a NA study of Marijuana Dependence that has completed, run by UConn Health. The registered enrollment target is 198 participants, above the 60-participant average among 6 other Marijuana Dependence trials with a reported enrollment target (230% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02030665, a NA study of Marijuana Dependence, has completed, sponsored by UConn Health.

COMPLETED
Registry status
NA
Development phase
198 participants
Enrollment target
1
Study location

Study Summary

Marijuana is the most commonly used illicit drug in the US, but treatment for marijuana dependence is not fully effective. In the current proposal we are exploring the idea that more tailored teaching of coping skills may result in improved outcomes for marijuana-dependence than those seen thus far. Participants will be 275 men and women meeting criteria for marijuana dependence and randomly assigned to 9 sessions of treatment in one of 4 treatment conditions: Standardized MET plus CB (SMET-CB); SMET+ CM (SMET-CB-CM); IATP; or IATP + CM (IATP-CM). Patients in all treatments will engage in ES via cell-phone for two weeks prior to treatment, for a weekly period during treatment, for another week after treatment has ended, and for two weekly periods at months 8 and 14. In the IATP conditions, the information gathered from the pretreatment and during-treatment ES periods will provide data for a functional analysis of patients' drug use and urges to use. It is hypothesized that IATP conditions will yield significantly better coping skills acquisition than SMET-CB conditions, both at posttreatment and at extended follow-ups, and that change in coping skills will predict better outcomes for the IATP conditions

Conditions Studied

Marijuana Dependence

Interventions

  • BEHAVIORAL Contingency Management
  • BEHAVIORAL Cognitive-Behavioral Treatment
  • BEHAVIORAL Individualized Assessment & Treatment

Study Locations (1)

Connecticut

  • University of Connecticut Health Center - Farmington

Trial Details

FieldValue
Enrollment Target 198 participants
Start Date 2013-02
Est. Completion 2018-04
Phase NA

Sponsor

UConn Health

178 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02030665

The ClinicalTrials.gov registry entry for NCT02030665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 60-participant average among 6 other Marijuana Dependence trials with a reported enrollment target (230% higher). The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Marijuana Dependence appearing as the primary indexed condition, and to 3 interventions - of which Contingency Management is the first listed.

NCT02030665 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT02030665 about?

NCT02030665 is a clinical study titled "Marijuana Treatment Project 4". Marijuana is the most commonly used illicit drug in the US, but treatment for marijuana dependence is not fully effective. In the current proposal we are exploring the idea that more tailored teaching of coping skills may result in improved outcomes for marijuana-dependence than those seen thus far....

What is the current status of trial NCT02030665?

This trial is currently completed. It is a NA study. The enrollment target is 198 participants. The study started on 2013-02. Estimated completion is 2018-04.

What conditions does trial NCT02030665 study?

This clinical trial studies the following conditions: Marijuana Dependence.

What interventions are being tested in trial NCT02030665?

The interventions under investigation include: Contingency Management (BEHAVIORAL), Cognitive-Behavioral Treatment (BEHAVIORAL), Individualized Assessment & Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT02030665?

This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02030665 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Marijuana Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Marijuana Dependence

All registered trials for this condition

Connecticut

All trials with a study site in Connecticut

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.